Actively Recruiting
Impact of Cannabis Consumption on the Course, Modalities of Hospitalization and the Short-term Prognosis of Inpatients Suffering From Psychotic Symptoms
Led by Centre hospitalier de Ville-Evrard, France · Updated on 2024-03-15
200
Participants Needed
1
Research Sites
519 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Few studies have evaluated, in patients with symptomatology the impact of cannabis use on the duration of hospitalization and on short- and medium-term developments. The objective of this study will be to assess the impact of cannabis on the duration, the hospitalization and the short- and medium-term evolution of patients with psychotic symptoms and cannabis use. We hypothesize that these patients (in comparison with patients with psychotic symptomatology and not using cannabis) would be hospitalized more long, exposed to a higher risk of resistance to the usual therapeutics, would have a lack of therapeutic alliance and insight, relapses and hospitalizations more frequent, more marked negative symptoms and lower quality remission. They would also be more prone to impulsive and aggressive behaviour.
CONDITIONS
Official Title
Impact of Cannabis Consumption on the Course, Modalities of Hospitalization and the Short-term Prognosis of Inpatients Suffering From Psychotic Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized in psychiatry regardless of the mode of hospitalization
- With or without protective measures such as guardianship or curatorship
- Presenting psychotic symptoms including schizophrenia, schizoaffective disorder, thymic disorder with psychotic features, substance-induced psychotic disorder, brief psychotic disorder, schizophrenic disorders, or delirious disorders
- Member of the social security system
- Provided informed consent
You will not qualify if you...
- Having degenerative neurological diseases or intellectual disability
- Psychotic disorders caused by general medical conditions like epilepsy, delirium tremens, or tumors
- Presence of other psychiatric disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
unité de recherche clinique de l'E.P.S de Ville Evrard
Neuilly-sur-Marne, France, 93332
Actively Recruiting
Research Team
R
RUSHEENTHIRA THAVASEELAN, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here